Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials

5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Future work: There is a pressing need to increase the evidence base to support decision making about all aspects of trial methodology. Trial registration: ISRCTN-22488978; ClinicalTrials.gov-NCT00058032. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16/46/01. The long-term follow-up UKCTOCS (2015 20) was supported by National Institute for Health and Care Research (NIHR HTA grant 16/46/01), Cancer Research UK, and The Eve Appeal. UKCTOCS (2001-14) was funded by the MRC (G9901012 and G0801228), Cancer Research UK (C1479/A2884), and the UK Department of Health, with additional support from The Eve Appeal. Researchers at UCL were supported by the NIHR UCL Hospitals Biomedical Research Centre and by the MRC Clinical Trials Unit at UCL core funding (MC_UU_00004/09, MC_UU_00004/08, MC_UU_00004/07). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the UK Department of Health and Social Care.

Cite

CITATION STYLE

APA

Menon, U., Gentry-Maharaj, A., Burnell, M., Apostolidou, S., Ryan, A., Kalsi, J. K., … Jacobs, I. J. (2023). Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials. Health Technology Assessment (Winchester, England), 29(10), 1–48. https://doi.org/10.3310/CLDC7214

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free